Search Results for "RHE35901"

ProteoGenix Receives European Funding to Develop a Therapeutic Antibody for the Treatment of Inflammatory Rheumatic Diseases

ProteoGenix Receives European Funding to Develop a Therapeutic Antibody for the Treatment of Inflammatory Rheumatic Diseases April 12, 2021 In a project coordinated by ImmunOs Therapeutics AG and in partnership with Amsterdam UMC, ProteoGenix prepares to tackle an unmet medical need and alleviate the burden… Read More

ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies

ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies October 29, 2019 Schiltigheim, France – For researchers looking to accelerate the development of new immunotechnologies, ProteoGenix has created 2 new naïve rabbit and human antibody… Read More

Assistant(e) Recherche & Développement

Type d’offre : Emploi à temps plein Vous rejoignez une société de biotechnologie créée en 2003 dont le chiffre d’affaires affiche une croissance moyenne de 20 à 50% par an. ProteoGenix commercialise des produits et services dans le domaine des biotechnologies à… Read More

Assistant(e) Recherche & Développement

  Type d’offre : Stage Vous rejoignez une société de biotechnologie créée en 2003 dont le chiffre d’affaires affiche une croissance moyenne de 20 à 50% par an. ProteoGenix commercialise des produits et services dans le domaine des biotechnologies à destination de laboratoires de… Read More

Chargé(e) d’affaires – Synthèse de gènes et production d’anticorps polyclonaux

Type d’offre : Emploi à plein temps   Vous rejoignez une société de biotechnologie créée en 2003 dont le chiffre d’affaires affiche une croissance moyenne de 20 à 50% par an. ProteoGenix commercialise des produits et services dans le domaine des biotechnologies à… Read More

What are the main cell lines used for the stable production of monoclonal antibodies?

The stable production of antibodies, particularly therapeutic monoclonal antibodies, has long been dominated by mammalian recombinant systems. Despite their complex genetic background, cell lines like Chinese hamster ovary (CHO) and murine myeloma cells, are very amenable to growth in suspension in serum-free medium and highly tolerant to changes… Read More

Bioreagents for Therapeutic Research

Read More

Download the complete SPR report

Download the complete SPR report Request the complete SPR PDF file and discover: an example of report you could get by choosing ProteoGenix as your antibody KD measurement partner, the full-set of data including additional analysis. Read More

Download the complete Recombinant antibody production report

Case Study Download the complete Recombinant Antibody Production Report! Discover the contents: An example of a report you could get by choosing ProteoGenix as your recombinant antibody production partner The full set of data including additional analysis Get your report… Read More

What are the benefits of using recombinant antibodies?

Recombinant antibodies are useful for many applications. Unlike conventional monoclonal antibodies produced in hybridomas, recombinant antibodies can be produced in different high-yield expression systems. But although diagnostic and therapeutic antibodies are generally produced in recombinant systems, most research antibodies are still produced in hybridomas. However, there are many… Read More